Q1 2022 Holdings
Filed 2022-05-16 | 122 holdings | $414.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Natera Inc | NOTE 2.250% 5/0 | 632307AB0 | $120.2K | $90,638,000 | 0.0% |
| Caremax Inc | COM CL A | 14171W103 | $121.8K | 15,861,090 | 0.0% |
| Envista Holdings Corporation | NOTE 2.375% 6/0 | 29415FAB0 | $123.9K | $52,500,000 | 0.0% |
| Aerie Pharmaceuticals Inc | NOTE 1.500%10/0 | 00771VAB4 | $141.9K | $157,390,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $155.4K | 1,657,800 | 0.0% |
| Invitae Corp | NOTE 2.000% 9/0 | 46185LAB9 | $169.8K | $206,873,000 | 0.0% |
| Viatris Inc(VTRS) | COM | 92556V106 | $224.9K | 20,673,700 | 0.1% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $268.6K | 19,341,024 | 0.1% |
| Glaukos Corp | NOTE 2.750% 6/1 | 377322AB8 | $358.8K | $269,897,000 | 0.1% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $942.0K | 464,252 | 0.2% |
| Annexon Inc(ANNX) | COM | 03589W102 | $1.6M | 583,913 | 0.4% |
| Acutus MED Inc(AFIB) | COM | 005111109 | $3.7M | 2,648,386 | 0.9% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $3.9M | 375,585 | 0.9% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $8.8M | 584,136 | 2.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $12.0M | 1,601,000 | 2.9% |
| Alector Inc(ALEC) | COM | 014442107 | $15.0M | 1,055,192 | 3.6% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $16.5M | 1,012,000 | 4.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $35.1M | 952,703 | 8.5% |
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $37.9M | 5,379,000 | 9.2% |
| Alphatec Hldgs Inc(ATEC) | COM NEW | 02081G201 | $41.3M | 3,594,829 | 10.0% |
| Centene Corp del(CNC) | COM | 15135B101 | $46.6M | 553,800 | 11.3% |
| Adapthealth Corp(AHCO) | COMMON STOCK | 00653Q102 | $186.8M | 11,650,072 | 45.1% |